An Observation of Fluvoxamine and Cognitive Behavioral Therapy in Emotional Disorder Children and Adolescents
Objective To analyze the efficacy of fluvoxamine combined with cognitive-behavioral therapy in treating mood disorders in children and adolescents.Methods A total of 100 cases of children and adolescents with mood disorders were selected from the First Affiliated Hospital of Xinjiang Medical University between January 2020 and December 2022 as subjects for the study.The subjects were grouped according to a random odd-even lottery method.A random number generator was used to determine the allocation of cases into the control and research groups.Each group comprised 50 cases,and the control group received a single fluvoxamine treatment,while the research group received fluvoxamine in combination with cognitive behavioral therapy.The two groups were compared before and after treatment with the scores of the following instruments:the Children's Depression Rating Scale(CDRS),the Screen for Child Anxiety Related Emotional Disorders(SCARED),the Children's Global Assessment Scale(CGAS),and the Children's and Adolescents'Quality of Life Scale(QLSCA).Results The difference between the DSRSC and SCARED scores of the two groups before treatment was not statistically significant(P＞0.05).However,the DSRSC and SCARED scores of the two groups after treatment were lower than before treatment.Furthermore,the assessment scores of the research group were lower than those of the control group,and the difference was statistically significant(P＜0.05).5)The difference between the CGAS scores of the two groups before treatment was not statistically significant(P＞0.05),and after treatment,the CGAS scores of the two groups were higher than before treatment.The assessment scores of the research group were higher than those of the control group,and the differences were statistically significant(P＜0.05).The scores of the QLSCA dimensions between the two groups before treatment were not statistically significant(P＞0.05).However,the scores of the QLSCA dimensions of the two groups after treatment were higher than those of the pre-treatment period.Furthermore,the assessment scores of the research group were higher than those of the control group,and the differences were all statistically significant(P＜0.05).Conclusion The combination of fluvoxamine and cognitive-behavioral therapy for mood disorders in children and adolescents has been demonstrated to result in superior therapeutic outcomes for both anxiety and depression,while simultaneously enhancing quality of life.This approach is therefore worthy of further investigation.
fluvoxaminecognitive behavioral therapyemotional disorder in children and adolescents
国家科技期刊平台
NSTL
万方数据
